After being fined last month for violating ISA virus control, now it has been convicted as a repeat offender for failing to report a veterinary treatment in time.
A court rejected the company's appeal and upheld the sanction even though it was proven there was an error by the Health Condition Certifier and the laboratory.
Presenting the Q4 results, CEO Nina Willumsen Grieg outlined the company's strategic shift from global growth to regional profitability, including land-based post-smolt investment.